Experimental drug auxora tested in severe COVID-19 pneumonia – study halted early
Disease control
Terminated
This study tested a drug called Auxora in 10 critically ill patients with COVID-19 pneumonia who were on ventilators. The main goal was to see how the drug affected immune cells in the lungs and to check its safety. The study was terminated early, so results are limited.
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC